Advertisement
Browse in-depth TOC on Obama's Healthcare Reform Market Report. Earlybuyers will receive 10% customization of reportshttp://www.marketsandmarkets.com/Market-Reports/Impact-Obama-Health-US-240.html
Advertisement
(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)
Report description
The US healthcare system ranks 37 among health care systems of about 200worldwide countries ranked by World Health Organization. US health caresystem is considered as one of the most expensive healthcare system in theworld, spending about 16% of its GDP on healthcare. However the risinghealthcare costs and increasing health premiums rates along with high numberof uninsured people (about 47 million i.e. 16% of the total population) areamong the significant factors contributing to the need of health reform inthe US. Health reform in the US is looked upon as an initiative towardsprovision of qualitative and affordable health coverage for all Americans,decrease in rising burden of healthcare costs and improvement in quality &efficiency of health care. Obama has signed health reform in to law, recentlyin March 2010, to improve the inefficiencies of the existing health carestructure. The health reform bill outlays several provisions such asuniversal health coverage, cost containment, increase in insurance marketcompetition, excise tax on medical device manufacturers and lower drug costsfor Medicaid and Medicare are few to mention. Thus the provisions in thehealth reform directly and indirectly impact the US healthcare/pharmaceuticalindustry and its stakeholders.
SCOPE AND FORMAT
The report will enable understanding of following key areas related toObama's health reform
INFORMATION SOURCES
Each of the section will provide market data, key findings and strategicanalysis related to US healthcare structure or Obama's health reforms. Inaddition the report also provides impact analysis of Obama's health reform onthe US healthcare industry from different prospective such as impact onhealthcare industry stakeholders, drug & medical device manufacturers andimpact analysis of several provisions of health reforms onhealthcare/pharmaceutical industry. Secondary research will progress throughboth paid and unpaid sources. We will conduct primary research to providein-depth understanding of the healthcare structure in the US and impact ofObama's health reforms on the healthcare/pharmaceutical industry.
About MarketsandMarkets
MarketsandMarkets (M&M) is a global market research and consultingcompany based in the U.S. We publish strategically analyzed market researchreports and serve as a business intelligence partner to Fortune 500 companiesacross the world. MarketsandMarkets also provides multi-client reports,company profiles, databases, and custom research services.
M&M covers thirteen industry verticals, including advanced materials,automotive and transportation, banking and financial services, biotechnology,chemicals, consumer goods energy and power, food and beverages, industrialautomation, medical devices, pharmaceuticals, semiconductor and electronics,and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow byproviding apt business insight with our huge market intelligence repository.To know more about us and our reports, please visit our websitehttp://www.marketsandmarkets.comKey take aways - To describe US healthcare system - To identify the need of the health reform in the US - To analyze Obama's health reforms and other initiatives in health care sector - Analyze and discuss the benefits and challenges of Obama's health reforms - Impact analysis of Obama's health reform on the pharmaceutical, biotech and medical devices industry - To study the impact of Obama's health reforms on payers, providers and beneficiaries & consumers of the US healthcare system - Analyze the impact of various provisions of Obama's health reform - Economic impact of Obama's health reform
SOURCE Markets and Markets
